EASTERN COOPERATIVE ONCOLOGY GROUP-- OPERATIONS OFFICE
东方肿瘤合作组--运营办公室
基本信息
- 批准号:2086914
- 负责人:
- 金额:$ 440.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-09-01 至 1995-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS biological response modifiers bone marrow transplantation brain neoplasms breast neoplasms cancer prevention clinical trials combination cancer therapy combination chemotherapy cooperative study gastrointestinal neoplasms head /neck neoplasm human subject human therapy evaluation karyotype leukemia lymphoma melanoma multiple myeloma neoplasm /cancer chemotherapy neoplasm /cancer genetics neoplasm /cancer immunotherapy neoplasm /cancer pharmacology neoplasm /cancer radiation therapy neoplasm /cancer surgery reproductive system neoplasm sarcoma thorax neoplasm urinary tract neoplasms
项目摘要
The Eastern cooperative Oncology Group (ECOG), one of the largest
clinical cooperative groups in the country, proposes to continue serving
as a Research Base for the 21 applicant programs comprising its Community
Clinical Oncology Program (CCOP). The ECOG Research Base has recently
undergone significant evolution to improve and expand its cancer
prevention and control research capacity. In this proposal, five years
of additional support is requested to continue this on-going process of
improving and expanding the ECOG Research Base to better serve the needs
of the CCOP programs. To meet its on-going responsibilities as a Research
Base, ECOG will focus its efforts on the following: 1) Continue to expand
and strengthen its cancer prevention, control and treatment research
capacity within the CCOP programs and other ECOG participants; 2)
Continue to stimulate the development of state-of-the science NCI-
approved cancer prevention and control intervention protocols to the CCOP
programs and other ECOG participants, including research protocols that
specifically target women and underserved populations; 3) Continue to
provide the network of community-based physicians and hospitals in ECOG
with the necessary services and resources to support state-of-the-science
cancer research in the community, including protocol development, patient
accrual, data management and quality control, and analytic support; 4)
Continue to provide a wide variety of training workshops for the CCOPs,
including minority CCOPs, in patient accrual and data management, as well
as ECOG, NCI, and FDA procedures and regulations; 5) Continue to provide
the CCOPs with the leadership and administrative services described above
through the ECOG Operations office and the ECOG Statistical Center, and
continue the on-going process of making these key organizational units
more responsive to the needs of the CCOP program; 6) Continue to pursue
an aggressive program of community-based cancer prevention and control
research by being responsive to NCI requests and priority areas in this
regard; 7) Continue to fulfill the mandated responsibilities of the
Research Base in evaluating and monitoring the activities of the CCOPs
through site visits, meetings, progress reports and performance reviews.
东部肿瘤合作组织 (ECOG),最大的组织之一
全国临床合作团体,建议继续服务
作为组成其社区的 21 个申请项目的研究基地
临床肿瘤学计划(CCOP)。 ECOG研究基地最近
经历了显着的进化以改善和扩大其癌症
防控研究能力。在这个提案中,五年
需要额外的支持来继续这一持续的进程
改进和扩大ECOG研究基地,以更好地满足需求
CCOP 计划的一部分。履行其作为研究机构的持续职责
基地,ECOG将重点做好以下工作:1)继续扩大规模
加强癌症预防、控制和治疗研究
CCOP 计划和其他 ECOG 参与者的能力; 2)
继续刺激NCI最先进的科学发展
向 CCOP 批准癌症预防和控制干预方案
计划和其他 ECOG 参与者,包括研究协议
特别针对妇女和服务不足的人群; 3)继续
提供 ECOG 社区医生和医院网络
提供必要的服务和资源来支持最先进的技术
社区癌症研究,包括方案制定、患者
应计、数据管理和质量控制以及分析支持; 4)
继续为 CCOP 提供各种培训研讨会,
包括少数族裔 CCOP,以及患者应计和数据管理
ECOG、NCI 和 FDA 程序和法规; 5)继续提供
具有上述领导和行政服务的 CCOP
通过ECOG业务办公室和ECOG统计中心,以及
继续正在进行的创建这些关键组织单位的过程
更好地响应 CCOP 计划的需求; 6)继续追求
积极的社区癌症预防和控制计划
通过响应 NCI 的请求和该领域的优先领域进行研究
看待; (七)继续履行法定职责
评估和监测 CCOP 活动的研究基地
通过实地考察、会议、进度报告和绩效审查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLASS C TORMEY其他文献
DOUGLASS C TORMEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLASS C TORMEY', 18)}}的其他基金
EASTERN COOPERATIVE ONCOLOGY GROUP--OPERATIONS OFFICE
东方肿瘤合作组--运营办公室
- 批准号:
2086916 - 财政年份:1992
- 资助金额:
$ 440.96万 - 项目类别:
相似海外基金
Development of biological response modifiers of neurotrophins and their receptors
神经营养素及其受体生物反应调节剂的开发
- 批准号:
171953 - 财政年份:2008
- 资助金额:
$ 440.96万 - 项目类别:
Operating Grants
Collection, Storage, Advertisements, & Distribut of Biological Response Modifiers
收藏、保管、广告、
- 批准号:
7789037 - 财政年份:2006
- 资助金额:
$ 440.96万 - 项目类别:
Collection, Storage, Advertisements, & Distribut of Biological Response Modifiers
收藏、保管、广告、
- 批准号:
8089733 - 财政年份:2006
- 资助金额:
$ 440.96万 - 项目类别:
Design and development of biological response modifiers
生物反应调节剂的设计和开发
- 批准号:
14103018 - 财政年份:2002
- 资助金额:
$ 440.96万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7624158 - 财政年份:2001
- 资助金额:
$ 440.96万 - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7867872 - 财政年份:2001
- 资助金额:
$ 440.96万 - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6616667 - 财政年份:2001
- 资助金额:
$ 440.96万 - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7440233 - 财政年份:2001
- 资助金额:
$ 440.96万 - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6758547 - 财政年份:2001
- 资助金额:
$ 440.96万 - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7142856 - 财政年份:2001
- 资助金额:
$ 440.96万 - 项目类别: